Many pieces of research revealed that STING is an effective strategy for inducing the progression of pancreatic cancer and consequently anti-tumor activity, which has been recently applied to other therapies such as vaccines and immune-targeted nanoparticles. The gene discussed is STING1; the disease is familial pancreatic carcinoma.